296
A. S. Shinde et al.
170. Salvador A, Igartua M, Hernández RM, Pedraz JL (2012) Combination of immune stimulating
adjuvants with poly (lactide-co-glycolide) microspheres enhances the immune response of
vaccines. Vaccine 30:589–596
171. Dobrovolskaia M, McNeil S (2013) Handbook of immunological properties of engineered
nanomaterials, vol 1. World Scientific Publishing, Singapore
172. Napierska D, Quarck R, Thomassen LC, Lison D, Martens JA, Del-croix M, Nemery B, Hoet
PH (2012) Amorphous silica nanoparticles promote monocyte adhesion to human endothelial
cells: size-dependent effect. Small 9:430–438. https://doi.org/10.1002/smll.201201033
173. Morishige T, Yoshioka Y, Inakura H, Tanabe A, Yao X, Narimatsu S, Monobe Y, Imazawa T,
Tsunoda SI, Tsutsumi Y, Mukai Y (2010) The effect of surface modification of amorphous
silica particles on NLRP3 inflammasome mediated IL-1β production, ROS production and
endosomal rupture. Biomaterials 31:6833–6842
174. Boraschi D, Italiani P, National I (2012) Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. Nanomedicine 7:121–131. https://doi.org/10.2217/nnm.
11.169
175. Elsherbini AA, Saber M, Aggag M, El-Shahawy A, Shokier HA (2011) Laser and
radiofrequency-induced hyperthermia treatment via gold-coated magnetic nanocomposites.
Int J Nanomedicine 6:2155
176. Elsherbini AA, Saber M, Aggag M, El-Shahawy A, Shokier HA (2011) Magnetic nanoparticleinduced hyperthermia treatment under magnetic resonance imaging. Magn Reson Imaging
29:272–280
177. Hsiao I-L, Huang Y-J (2011) Titanium oxide shell coatings decrease the cytotoxicity of ZnO
nanoparticles. Chem Res Toxicol 24:303–313. https://doi.org/10.1021/tx1001892
178. Arora HC, Jensen MP, Yuan Y, Wu A, Vogt S, Paunesku T, Woloschak GE (2012) Nanocarriers
enhance doxorubicin uptake in drug-resistant ovarian cancer cells. Cancer Res 72:769–778.
https://doi.org/10.1158/0008-5472.CAN-11-2890
179. Nohynek GJ, Dufour EK (2012) Nano-sized cosmetic formulations or solid nanoparticles in
sunscreens: a risk to human health? Arch Toxicol 86:1063–1075. https://doi.org/10.1007/s00
204-012-0831-5
180. Davis MM (2008) A prescription for human immunology. Immunity 29:835–838
181. Gagliardi M, Bardi G, Bifone A (2012) Polymeric nanocarriers for controlled and enhanced
delivery of therapeutic agents to the CNS. Ther Deliv 3:875–887
A. S. Shinde et al.
170. Salvador A, Igartua M, Hernández RM, Pedraz JL (2012) Combination of immune stimulating
adjuvants with poly (lactide-co-glycolide) microspheres enhances the immune response of
vaccines. Vaccine 30:589–596
171. Dobrovolskaia M, McNeil S (2013) Handbook of immunological properties of engineered
nanomaterials, vol 1. World Scientific Publishing, Singapore
172. Napierska D, Quarck R, Thomassen LC, Lison D, Martens JA, Del-croix M, Nemery B, Hoet
PH (2012) Amorphous silica nanoparticles promote monocyte adhesion to human endothelial
cells: size-dependent effect. Small 9:430–438. https://doi.org/10.1002/smll.201201033
173. Morishige T, Yoshioka Y, Inakura H, Tanabe A, Yao X, Narimatsu S, Monobe Y, Imazawa T,
Tsunoda SI, Tsutsumi Y, Mukai Y (2010) The effect of surface modification of amorphous
silica particles on NLRP3 inflammasome mediated IL-1β production, ROS production and
endosomal rupture. Biomaterials 31:6833–6842
174. Boraschi D, Italiani P, National I (2012) Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. Nanomedicine 7:121–131. https://doi.org/10.2217/nnm.
11.169
175. Elsherbini AA, Saber M, Aggag M, El-Shahawy A, Shokier HA (2011) Laser and
radiofrequency-induced hyperthermia treatment via gold-coated magnetic nanocomposites.
Int J Nanomedicine 6:2155
176. Elsherbini AA, Saber M, Aggag M, El-Shahawy A, Shokier HA (2011) Magnetic nanoparticleinduced hyperthermia treatment under magnetic resonance imaging. Magn Reson Imaging
29:272–280
177. Hsiao I-L, Huang Y-J (2011) Titanium oxide shell coatings decrease the cytotoxicity of ZnO
nanoparticles. Chem Res Toxicol 24:303–313. https://doi.org/10.1021/tx1001892
178. Arora HC, Jensen MP, Yuan Y, Wu A, Vogt S, Paunesku T, Woloschak GE (2012) Nanocarriers
enhance doxorubicin uptake in drug-resistant ovarian cancer cells. Cancer Res 72:769–778.
https://doi.org/10.1158/0008-5472.CAN-11-2890
179. Nohynek GJ, Dufour EK (2012) Nano-sized cosmetic formulations or solid nanoparticles in
sunscreens: a risk to human health? Arch Toxicol 86:1063–1075. https://doi.org/10.1007/s00
204-012-0831-5
180. Davis MM (2008) A prescription for human immunology. Immunity 29:835–838
181. Gagliardi M, Bardi G, Bifone A (2012) Polymeric nanocarriers for controlled and enhanced
delivery of therapeutic agents to the CNS. Ther Deliv 3:875–887